Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 3,310.00
+35.00 (1.07%)
Last updated: Aug 6, 2026, 2:35 PM KST
Kukje Pharma Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9,081 | 10,703 | 8,678 | 10,590 | 5,539 | 7,866 |
Short-Term Investments | 226.58 | - | - | - | - | - |
Trading Asset Securities | 69.67 | 20.34 | 76.49 | 42.29 | 20.18 | 36.91 |
Cash & Short-Term Investments | 9,377 | 10,724 | 8,755 | 10,632 | 5,559 | 7,903 |
Cash Growth | -5.59% | 22.49% | -17.66% | 91.26% | -29.66% | 84.93% |
Accounts Receivable | 25,986 | 23,978 | 22,761 | 20,429 | 19,131 | 20,653 |
Other Receivables | 4,256 | 4,552 | 741.8 | 708.07 | 1,222 | 2,819 |
Receivables | 31,579 | 29,845 | 24,656 | 22,141 | 20,359 | 23,486 |
Inventory | 23,728 | 25,850 | 22,369 | 21,243 | 22,235 | 16,540 |
Prepaid Expenses | 8.48 | 25.64 | 28.94 | 35.34 | 35.21 | 23.51 |
Other Current Assets | 28.55 | 933.2 | 1,165 | 1,067 | 347.29 | 244.12 |
Total Current Assets | 64,721 | 67,377 | 56,974 | 55,119 | 48,535 | 48,197 |
Property, Plant & Equipment | 99,209 | 98,443 | 98,185 | 99,124 | 78,380 | 81,981 |
Long-Term Investments | 8,003 | 8,772 | 4,545 | 3,195 | 3,984 | 3,953 |
Other Intangible Assets | 1,346 | 1,386 | 870.1 | 919.29 | 944.49 | 935.19 |
Long-Term Deferred Charges | 0 | 0 | 0 | 0 | 180.95 | 398.08 |
Other Long-Term Assets | 5,647 | 6,298 | 4,824 | 4,902 | 4,569 | 4,319 |
Total Assets | 178,926 | 182,276 | 165,548 | 163,259 | 136,593 | 139,783 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 10,273 | 15,834 | 11,064 | 8,564 | 7,068 | 7,249 |
Accrued Expenses | 955.35 | 1,034 | 893.87 | 918.01 | 1,235 | 1,110 |
Short-Term Debt | 3,000 | 3,000 | 2,000 | 30,000 | 27,000 | 32,000 |
Current Portion of Long-Term Debt | 27,000 | 27,000 | - | - | - | 2,000 |
Current Portion of Leases | 193.44 | 110.2 | 169.69 | 186.34 | 399.95 | 366.36 |
Current Income Taxes Payable | 1,215 | 986.15 | 1,372 | 1,566 | 1,488 | 302.48 |
Other Current Liabilities | 16,572 | 14,055 | 13,047 | 18,453 | 10,664 | 11,489 |
Total Current Liabilities | 59,209 | 62,020 | 28,547 | 59,687 | 47,855 | 54,517 |
Long-Term Debt | - | - | 27,000 | - | - | - |
Long-Term Leases | 726.63 | 293.79 | 341.94 | 475.74 | 1,196 | 1,620 |
Pension & Post-Retirement Benefits | - | - | 1,824 | - | 1,244 | 5,272 |
Long-Term Deferred Tax Liabilities | 12,939 | 13,265 | 12,724 | 13,054 | 7,895 | 7,248 |
Other Long-Term Liabilities | 7,548 | 8,995 | 5,562 | 5,092 | 4,323 | 2,538 |
Total Liabilities | 80,422 | 84,574 | 75,999 | 78,310 | 62,514 | 71,195 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 21,160 | 21,160 | 21,160 | 21,160 | 20,195 | 19,276 |
Additional Paid-In Capital | 3,359 | 3,359 | 2,360 | 2,094 | 3,059 | 3,978 |
Retained Earnings | 12,116 | 10,661 | 5,406 | -3,391 | 6,327 | 1,095 |
Treasury Stock | - | - | -2,253 | -2,566 | -2,535 | -2,494 |
Comprehensive Income & Other | 61,858 | 62,509 | 62,868 | 67,647 | 47,028 | 46,714 |
Total Common Equity | 98,494 | 97,689 | 89,542 | 84,944 | 74,074 | 68,568 |
Minority Interest | 9.79 | 13.64 | 6.39 | 5.49 | 5.19 | 19.75 |
Shareholders' Equity | 98,504 | 97,702 | 89,548 | 84,950 | 74,079 | 68,588 |
Total Liabilities & Equity | 178,926 | 182,276 | 165,548 | 163,259 | 136,593 | 139,783 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 30,920 | 30,404 | 29,512 | 30,662 | 28,596 | 35,987 |
Net Cash (Debt) | -21,543 | -19,680 | -20,757 | -20,030 | -23,037 | -28,084 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1046.71 | -965.47 | -1020.85 | -988.96 | -1137.06 | -1385.71 |
Filing Date Shares Outstanding | 21.16 | 21.16 | 20.36 | 20.25 | 20.26 | 20.27 |
Total Common Shares Outstanding | 21.16 | 21.16 | 20.36 | 20.25 | 20.26 | 20.27 |
Working Capital | 5,512 | 5,358 | 28,427 | -4,568 | 680.31 | -6,319 |
Book Value Per Share | 4654.76 | 4616.70 | 4397.39 | 4194.43 | 3656.47 | 3383.53 |
Tangible Book Value | 97,148 | 96,302 | 88,672 | 84,025 | 73,130 | 67,633 |
Tangible Book Value Per Share | 4591.15 | 4551.19 | 4354.66 | 4149.04 | 3609.85 | 3337.38 |
Land | 72,064 | 72,064 | 72,064 | 72,736 | 46,629 | 46,808 |
Buildings | 23,270 | 23,270 | 25,051 | 25,563 | 26,478 | 26,804 |
Machinery | 49,190 | 48,110 | 50,847 | 39,015 | 40,488 | 41,862 |
Construction In Progress | 2,000 | 2,307 | 349.3 | 91.5 | 123 | 151.85 |